149 related articles for article (PubMed ID: 15472910)
1. Treatment of AIDS-associated Kaposi's sarcoma in Zimbabwe: results of a randomized quality of life focused clinical trial.
Olweny CL; Borok M; Gudza I; Clinch J; Cheang M; Kiire CF; Levy L; Otim-Oyet D; Nyamasve J; Schipper H
Int J Cancer; 2005 Feb; 113(4):632-9. PubMed ID: 15472910
[TBL] [Abstract][Full Text] [Related]
2. Kaposi's sarcoma in children: an open randomised trial of vincristine, oral etoposide and a combination of vincristine and bleomycin.
Chagaluka G; Stanley C; Banda K; Depani S; Nijram'madzi J; Katangwe T; Israels T; Bailey S; Mukaka M; Molyneux E
Eur J Cancer; 2014 May; 50(8):1472-81. PubMed ID: 24636877
[TBL] [Abstract][Full Text] [Related]
3. Treatment of epidemic Kaposi's sarcoma with etoposide or a combination of doxorubicin, bleomycin, and vinblastine.
Laubenstein LJ; Krigel RL; Odajnyk CM; Hymes KB; Friedman-Kien A; Wernz JC; Muggia FM
J Clin Oncol; 1984 Oct; 2(10):1115-20. PubMed ID: 6208343
[TBL] [Abstract][Full Text] [Related]
4. The role of chemotherapy for epidemic Kaposi's sarcoma.
Volberding PA
Semin Oncol; 1987 Jun; 14(2 Suppl 3):23-6. PubMed ID: 2440109
[TBL] [Abstract][Full Text] [Related]
5. Phase II evaluation of low-dose oral etoposide for the treatment of relapsed or progressive AIDS-related Kaposi's sarcoma: an AIDS Clinical Trials Group clinical study.
Evans SR; Krown SE; Testa MA; Cooley TP; Von Roenn JH
J Clin Oncol; 2002 Aug; 20(15):3236-41. PubMed ID: 12149296
[TBL] [Abstract][Full Text] [Related]
6. Clinical and pharmacokinetic study of oral etoposide in patients with AIDS-related Kaposi's sarcoma with no prior exposure to cytotoxic therapy.
Schwartsmann G; Sprinz E; Kromfield M; Kalakun L; Sander E; Prolla G; Di Leone L; Gerhardt L; Mans DR
J Clin Oncol; 1997 May; 15(5):2118-24. PubMed ID: 9164226
[TBL] [Abstract][Full Text] [Related]
7. A risk and benefit assessment of treatment for AIDS-related Kaposi's sarcoma.
Nasti G; Errante D; Santarossa S; Vaccher E; Tirelli U
Drug Saf; 1999 May; 20(5):403-25. PubMed ID: 10348092
[TBL] [Abstract][Full Text] [Related]
8. [Kaposi's sarcoma in AIDS. 70 cases].
Lafeuillade A; Poizot-Martin I; Dhiver C; Giovannini M; Viallat JR; Quilichini R; Bouabdallah R; Gastaut JA
Presse Med; 1991 Jan; 20(3):113-6. PubMed ID: 1705701
[TBL] [Abstract][Full Text] [Related]
9. Virologic and immunologic parameters that predict clinical response of AIDS-associated Kaposi's sarcoma to highly active antiretroviral therapy.
Pellet C; Chevret S; Blum L; Gauvillé C; Hurault M; Blanchard G; Agbalika F; Lascoux C; Ponscarme D; Morel P; Calvo F; Lebbé C
J Invest Dermatol; 2001 Oct; 117(4):858-63. PubMed ID: 11676823
[TBL] [Abstract][Full Text] [Related]
10. The effect of HAART in 254 consecutive patients with AIDS-related Kaposi's sarcoma.
Bower M; Weir J; Francis N; Newsom-Davis T; Powles S; Crook T; Boffito M; Gazzard B; Nelson M
AIDS; 2009 Aug; 23(13):1701-6. PubMed ID: 19550283
[TBL] [Abstract][Full Text] [Related]
11. [Kaposi's sarcoma during HIV infection in Morocco (apropos of 50 cases)].
Chakib A; Hliwa W; Marih L; Himmich H
Bull Soc Pathol Exot; 2003 May; 96(2):86-9. PubMed ID: 12836521
[TBL] [Abstract][Full Text] [Related]
12. [Kaposi's sarcoma].
Imamura A
Gan To Kagaku Ryoho; 2003 May; 30(5):634-9. PubMed ID: 12795094
[TBL] [Abstract][Full Text] [Related]
13. Treatment of epidemic Kaposi's sarcoma with a combination of interferon-alpha 2b and etoposide.
Krigel RL; Slywotzky CM; Lonberg M; Green MD; Andes WA; Kempf R; Gupta S; Grace W; Spiegel RJ; Muggia FM
J Biol Response Mod; 1988 Aug; 7(4):359-64. PubMed ID: 3049944
[TBL] [Abstract][Full Text] [Related]
14. Weekly oral etoposide in patients with Kaposi's sarcoma associated with human immunodeficiency virus infection: a phase I multicenter trial of the AIDS Clinical Trials Group.
Paredes J; Kahn JO; Tong WP; Feldstein ML; Lin S; Bennett JM; Metroka CE; Ratner L; Krown SE
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jun; 9(2):138-44. PubMed ID: 7749790
[TBL] [Abstract][Full Text] [Related]
15. Radiotherapy in the management of epidemic Kaposi's sarcoma.
Piedbois P; Frikha H; Martin L; Levy E; Haddad E; Le Bourgeois JP
Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1207-11. PubMed ID: 7525519
[TBL] [Abstract][Full Text] [Related]
16. Experience with adriamycin, bleomycin, vincristine (ABV) palliative chemotherapy in advanced AIDS-related Kaposi's sarcoma.
Paparizos VA; Kyriakis KP; Mileounis KA; Pfandl-Polydorou D; Stavrianeas NG; Vareltzidis AG; Stratigos JD
J Chemother; 1996 Oct; 8(5):403-6. PubMed ID: 8957723
[TBL] [Abstract][Full Text] [Related]
17. Psychosocial considerations in the therapy of epidemic Kaposi's sarcoma.
Holland JC; Tross S
Semin Oncol; 1987 Jun; 14(2 Suppl 3):48-53. PubMed ID: 3603057
[TBL] [Abstract][Full Text] [Related]
18. Therapy of Kaposi's sarcoma in AIDS.
Volberding P
Semin Oncol; 1984 Mar; 11(1):60-7. PubMed ID: 6372100
[No Abstract] [Full Text] [Related]
19. Combination chemotherapy and alpha-interferon in the treatment of Kaposi's sarcoma associated with acquired immune deficiency syndrome.
Shepherd FA; Evans WK; Garvey B; Read SE; Klein M; Fanning MM; Coates R
CMAJ; 1988 Oct; 139(7):635-9. PubMed ID: 2458177
[TBL] [Abstract][Full Text] [Related]
20. Phase I/II trials of alpha-interferon alone or in combination with zidovudine as maintenance therapy following induction chemotherapy in the treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma.
Gill PS
Semin Oncol; 1991 Oct; 18(5 Suppl 7):53-7. PubMed ID: 1719642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
